FdaApplication
NDA 208341
Identifiers
- fda_app_no: NDA208341
Properties
| Property | Value |
|---|---|
| applicant_name | GILEAD SCIENCES INC |
| application_type | NDA |
| approval_date | 2016-06-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | 400MG;100MG | TABLET;ORAL |
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | 200MG;50MG | TABLET;ORAL |
2 products